PAIN
Volume 149, Issue 1 , Pages 7-8 , April 2010

A cure for back pain?

Received 12 May 2009 ,Accepted 22 May 2009.

References 

  1. Aaronov S, Ben-Abraham R, Givati-Divshi D, Katz Y. Involvement of nitric oxide in clonidine-induced spinal analgesia. Drug Metabol Drug Interact. 2005;21:41–53
  2. Hadjipavlou AG, Tzermiadianos MN, Bogduk N, Zindrick MR. The pathophysiology of disc degeneration: a critical review. J Bone Joint Surg. 2008;90:1261–1270
  3. Han X, Kobzik L, Zhao YY, Opel DJ, Liu WD, Kelly RA, et al. Nitric oxide regulation of atrioventricular excitability. Can J Cardiol. 1997;13:1191–1201
  4. Jesse CR, Savegnago L, Nogueira CW. Role of nitric oxide/cyclic GMP. K+ channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol. Life Sco. 2007;81:1694–1702
  5. Peng B, Chen J, Kuang Z, Li D, Pang X, Zhang X. Expression and role of connective tissue growth factor in painful disc fibrosis and degeneration. Spine. 2009;34:E178–E182
  6. Peng B, Hao J, Hou S, Wu W, Jiang D, Fu X, et al. Possible pathogenesis of painful intervertebral disc degeneration. Spine. 2006;31:560–566
  7. Peng B, Hou S, Wu W, Zhang C, Yang Y. The pathogenesis and clinical significance of a high-intensity zone (HIZ) of lumbar intervertebral disc on MR imaging in the patient with discogenic low back pain. Eur Spine J. 2006;15:583–587
  8. Peng B, Pang X, Wu Y, Zhao C, Song X. A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Pain. 2010;149:124–129
  9. Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. J Bone Joint Surg Br. 2005;87:62–67
  10. Zhou H, Hou S, Shang W, Wu W, Cheng Y, Mei F, et al. A new in vivo animal model to create intervertebral disc degeneration characterized by MRI, radiography, CT/discogram, biochemistry, and histology. Spine. 2007;32:864–872

PII: S0304-3959(09)00308-X

doi: 10.1016/j.pain.2009.05.022

PAIN
Volume 149, Issue 1 , Pages 7-8 , April 2010